Get started
Award

Anr-21-rhus-0017

Funded outputs count: 11
Funder award ID: ANR-21-RHUS-0017
OpenAlex ID: G7075379671
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling
2026 · Déborah Suissa, Marine Fidelle, et al. · Nature Medicine · 7
PDF
Inhibition of MAPK p38α overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation
2026 · Yuhong Pan, Liwei Zhao, et al. · Cell Reports Medicine · 4
Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis
2025 · Uxía Nogueira-Recalde, Flavia Lambertucci, et al. · Cell Death and Differentiation · 10
Fatty Acid Metabolism Provides an Essential Survival Signal in OxPhos and BCR DLBCL Cells
2025 · Aurélie Montagne, Konstantina Kotta, et al. · Biomedicines · 7
Metabolic Heterogeneity in Diffuse Large B-Cell Lymphoma Cells Reveals an Innovative Antimetabolic Combination Strategy
2025 · Leonardo Lordello, Stéphanie Nuan-Aliman, et al. · Cancers · 4
PDF
Neutralization of the autophagy-repressive tissue hormone DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) enhances anticancer immunosurveillance
2024 · Léa Montégut, Isabelle Martins, et al. · Autophagy · 5
The autophagy-repressive tissue hormone DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) suppresses anorexia
2024 · Hui Chen, Isabelle Martins, et al. · Autophagy · 6
PDF
A surge in endogenous spermidine is essential for rapamycin-induced autophagy and longevity
2024 · Sebastian J. Hofer, Ioanna Daskalaki, et al. · Autophagy · 25
PDF
Obesity-Associated Colorectal Cancer
2024 · Lucia Gonzalez-Gutierrez, Omar Motiño, et al. · International Journal of Molecular Sciences · 48
PDF
Targeted opening of the blood–brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma
2024 · Jonathan G. Pol, Manuela Lizarralde-Guerrero, et al. · OncoImmunology · 4
PDF
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies
2023 · Camille Bigenwald, Yacine Haddad, et al. · OncoImmunology · 11
PDF
Year
Topic